Zafiriou E, Karampinis E, Papadopoulos V, Stefani G, Kotsakis A, Vassilopoulos G. Non-Melanoma Skin Cancer Aggravation in Polycythemia Vera: Triggered by Ruxolitinib and Silenced With an IFN/Cemiplimab. Dermatol Pract Concept [Internet]. 2025 Jan. 29 [cited 2025 Dec. 12];15(1):4642. Available from: https://mail.dpcj.org/index.php/dpc/article/view/4642